ENTO
Entero Therapeutics
ENTO
ENTO
8 hedge funds and large institutions have $67.2K invested in Entero Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
UBS Group
Zurich,
Switzerland
|
$27.8K |
2 |
HF
2
HRT Financial
New York
|
$13K |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$17.6K |
4 |
JC
4
JB Capital
Wethersfield,
Connecticut
|
$4.8K |
5 |
SS
5
SBI Securities
Tokyo,
Japan
|
$1.59K |